4.4 Review

Nanoparticle Polymers Influence on Cardiac Health: Good or Bad for Cardiac Physiology?

期刊

CURRENT PROBLEMS IN CARDIOLOGY
卷 49, 期 1, 页码 -

出版社

MOSBY-ELSEVIER
DOI: 10.1016/j.cpcardiol.2023.102145

关键词

-

向作者/读者索取更多资源

Cardiovascular diseases are a major cause of death and morbidity worldwide. Nanoparticles and nanomaterials are increasingly being used as therapeutic and diagnostic modalities in the field of biomedicine. They can interact with the cardiovascular system in multiple ways, impacting cardiac physiology and cellular death. However, the use of nanoparticles can also lead to cardiotoxicity by increasing reactive oxidative species.
Cardiovascular diseases (CVD) are one of the leading causes of death and morbidity worldwide. Lifestyle modifications, medications, and addressing epidemiological factors have long been at the forefront of targeting therapeutics for CVD. Treatments can be further complicated given the intersection of gender, age, unique comorbidities, and healthcare access, among many other factors. Therefore, expanding treatment and diagnostic modalities for CVD is absolutely necessary. Nanoparticles and nanomaterials are increasingly being used as therapeutic and diagnostic modalities in various disciplines of biomedicine. Nanoparticles have multiple ways of interacting with the cardiovascular system. Some of them alter cardiac physiology by impacting ion channels, whereas others influence ions directly or indirectly, improving cellular death via decreasing oxidative stress. While embedding nanoparticles into therapeutics can help enhance healthy cardiovascular function in other scenarios, they can also impair physiology by increasing reactive oxidative species and leading to cardiotoxicity. This review explores different types of nanoparticles, their effects, and the applicable dosages to create a better foundation for understanding the current research findings.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据